texte alternatif                                    

    Liste de publications de Isabelle Demeestere


      Rapports de recherche, comptes rendus, lettres à l'éditeur, working papers (11)
  1. 11. Peccatori, F. A., & Demeestere, I. (2009). GnRH analogue for chemotherapy-induced ovarian damage: too early to say? Fertility and sterility, 92(2), e33. doi:10.1016/j.fertnstert.2009.06.002
    2.   Participations à des congrès et colloques internationaux (175)
  2. 1. Demeestere, I. (2024). Gene BRCA1 et fertilité des femmes présentant un cancer du sein: Invited speaker. Abstract session presented at Journée de recherche en préservation de la fertilité chez les patients atteints de cancer(02/12/2024: Paris)
  3. 2. Demeestere, I., et al. (2024). Effect of low, medium and high risk chemotherapy on the ovarian reserve in children: results of the interim analysis of a prospective multicentric trial (CHANCE): Invited Speaker. Session 24: Female fertility preservation - focus on outcomes Abstract session presented at ESHRE 40th Annual Meeting(40th: 7-10 July 2024: Amsterdam, The Netherlands)
  4. 3. Pening, D., Vegh, G., Leleux, F., Delbaere, A., Demeestere, I., & Lybaert, P. (2024). Evaluation of sperm capacitation as a parameter of male infertility diagnosis and impact of the cryopreservation process. Abstract session presented at 16th Meeting of the Network of Young Researchers in Andrology(May 27-29, 2024: Brussels)
  5. 4. Dias Nunes, J., Ntemou, E., Van Den Steen, G., & Demeestere, I. (2024). Carboplatin/paclitaxel exposure-induced gonadotoxicity in BRCA-mutated ovarian tissue. Abstract session presented at Séminaire Télévie(06/02/2024: Bruxelles, Belgium)
  6. 5. Dias Nunes, J., Ntemou, E., Van Den Steen, G., & Demeestere, I. (2024). Carboplatin/paclitaxel exposure-induced gonadotoxicity in BRCA-mutated ovarian tissue. Poster présenté à la conférence Séminaire télévie (06/02/2024: Bruxelles, Belgique).
  7. 6. Demeestere, I. (2024). Préservation de la fertilité : aspects oncologiques et gynécologiques: Invited speaker. Paper session presented at Société Luxembourgeoise de Gynécologie et d’Obstétrique (31/01/2024: Dommeldange, Luxembourg).
  8. 7. Dias Nunes, J., Ntemou, E., Van Den Steen, G., Devos, M., & Demeestere, I. (2023). Carboplatin/paclitaxel exposure-induced gonadotoxicity in BRCA-mutated ovarian tissue. Poster présenté à la conférence 50th Meeting of BSRM, Mons, 1-2 December 2023.
  9. 8. Demeestere, I. (2023). Fertility Preservation for Low/Medium Risk Youth: Invited speaker. Paper session presented at Conference of the Oncofortility Consortium (15th: 06-08/11/2023: Pittsburg, USA).
  10. 9. Demeestere, I. (2023). Fertility Preservation for BRCA Mutation Carriers: approach to counseling: Invited Speaker. Paper session presented at Conference of the Oncofortility Consortium (15th: 06-08/11/2023: Pittsburg, USA).
  11. 10. Demeestere, I. (2023). Optimisation du rendement folliculo-ovocytaire en onco-fertilité: Invited speaker. Paper session presented at Workshop Franco-Belge en Infertilité (FBI) (1: 13 October 2023: Lille, France).
  12. 11. Arecco, L., Blondeaux, E., Bruzzone, M., Latocca, M. M., Mariamidze, E., Begijanashvili, S., Sokolovic, E., Scavone, G., Ottonello, S., Boutros, A., Vaz-Luis, I., Saura, C., Anderson, R. A., Demeestere, I., Azim, H. A., de Azambuja, E., Del Mastro, L., Peccatori, F. A., Partridge, A. H., & Lambertini, M. (2023). Safety of pregnancy after early breast cancer in young women with hormone receptor-positive disease : a systematic review and meta-analysis. Paper session presented at ESHRE annual meeting (39 th: 25th-28th June 2023: Copenhagen, Denmark).
    13. << Précédent 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 Suivant >>